Literature DB >> 27042845

Evolution of serum cytokine profile after hematopoietic stem cell transplantation in systemic sclerosis patients.

L Michel1, D Farge2, J Baraut1, Z Marjanovic2, F Jean-Louis1, R Porcher3, E I Grigore1, C Deligny2, F Romijn4, L C M Arruda5,6, J van Pelt4, N Levarht7, F Verrecchia8, J M van Laar4,9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27042845     DOI： 10.1038/bmt.2016.77

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  16 in total

Review 1.  Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis.

Authors:  Julie Baraut; Laurence Michel; Franck Verrecchia; Dominique Farge
Journal:  Autoimmun Rev       Date:  2010-08-14       Impact factor: 9.754

Review 2.  The pathogenesis of systemic sclerosis.

Authors:  Tamiko R Katsumoto; Michael L Whitfield; M Kari Connolly
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

3.  Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study.

Authors:  J Baraut; E I Grigore; F Jean-Louis; S H Khelifa; C Durand; F Verrecchia; D Farge; L Michel
Journal:  Bone Marrow Transplant       Date:  2013-12-23       Impact factor: 5.483

4.  Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis.

Authors:  Minoru Hasegawa; Manabu Fujimoto; Takashi Matsushita; Yasuhito Hamaguchi; Kazuhiko Takehara; Shinichi Sato
Journal:  Clin Rheumatol       Date:  2010-11-04       Impact factor: 2.980

5.  Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis.

Authors:  L V Iversen; O Østergaard; S Ullman; C T Nielsen; P Halberg; T Karlsmark; N H H Heegaard; S Jacobsen
Journal:  Scand J Rheumatol       Date:  2013-09-09       Impact factor: 3.641

6.  Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor beta 1.

Authors:  R Giacomelli; P Cipriani; C Danese; F Pizzuto; R Lattanzio; I Parzanese; A Passacantando; M A Perego; G Tonietti
Journal:  J Rheumatol       Date:  1996-02       Impact factor: 4.666

7.  Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis.

Authors:  Dominique Farge; Corneliu Henegar; Maryvonnick Carmagnat; Marjan Daneshpouy; Zora Marjanovic; Claire Rabian; Doina Ilie; Corinne Douay; Nicolas Mounier; Emmanuel Clave; Djaouida Bengoufa; Jean Cabane; Jean Pierre Marolleau; Eliane Gluckman; Dominique Charron; Antoine Toubert
Journal:  Arthritis Rheum       Date:  2005-05

8.  Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial.

Authors:  Richard K Burt; Sanjiv J Shah; Karin Dill; Thomas Grant; Mihai Gheorghiade; James Schroeder; Robert Craig; Ikuo Hirano; Karin Marshall; Eric Ruderman; Borko Jovanovic; Francesca Milanetti; Sandeep Jain; Kristin Boyce; Amy Morgan; James Carr; Walter Barr
Journal:  Lancet       Date:  2011-07-21       Impact factor: 79.321

9.  Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations.

Authors:  Pravitt Gourh; Frank C Arnett; Shervin Assassi; Filemon K Tan; Mei Huang; Laura Diekman; Maureen D Mayes; John D Reveille; Sandeep K Agarwal
Journal:  Arthritis Res Ther       Date:  2009-10-02       Impact factor: 5.156

10.  Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial.

Authors:  Jacob M van Laar; Dominique Farge; Jacob K Sont; Kamran Naraghi; Zora Marjanovic; Jérôme Larghero; Annemie J Schuerwegh; Erik W A Marijt; Madelon C Vonk; Anton V Schattenberg; Marco Matucci-Cerinic; Alexandre E Voskuyl; Arjan A van de Loosdrecht; Thomas Daikeler; Ina Kötter; Marc Schmalzing; Thierry Martin; Bruno Lioure; Stefan M Weiner; Alexander Kreuter; Christophe Deligny; Jean-Marc Durand; Paul Emery; Klaus P Machold; Francoise Sarrot-Reynauld; Klaus Warnatz; Daniel F P Adoue; Joël Constans; Hans-Peter Tony; Nicoletta Del Papa; Athanasios Fassas; Andrea Himsel; David Launay; Andrea Lo Monaco; Pierre Philippe; Isabelle Quéré; Éric Rich; Rene Westhovens; Bridget Griffiths; Riccardo Saccardi; Frank H van den Hoogen; Willem E Fibbe; Gérard Socié; Alois Gratwohl; Alan Tyndall
Journal:  JAMA       Date:  2014-06-25       Impact factor: 56.272
View more
  14 in total

Review 1.  [Autologous stem cell transplantation in systemic sclerosis].

Authors:  J C Henes; S Wirths; I Kötter
Journal:  Z Rheumatol       Date:  2016-10       Impact factor: 1.372

2.  Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients.

Authors:  Lucas C M Arruda; Kelen C R Malmegrim; João R Lima-Júnior; Emmanuel Clave; Juliana B E Dias; Daniela A Moraes; Corinne Douay; Isabelle Fournier; Hélène Moins-Teisserenc; Antônio José Alberdi; Dimas T Covas; Belinda P Simões; Pauline Lansiaux; Antoine Toubert; Maria Carolina Oliveira
Journal:  Blood Adv       Date:  2018-01-23

3.  Myeloablation followed by autologous stem cell transplantation normalises systemic sclerosis molecular signatures.

Authors:  Shervin Assassi; Xuan Wang; Guocai Chen; Ellen Goldmuntz; Lynette Keyes-Elstein; Jun Ying; Paul K Wallace; Jacob Turner; W Jim Zheng; Virginia Pascual; John Varga; Monique E Hinchcliff; Chiara Bellocchi; Peter McSweeney; Daniel E Furst; Richard A Nash; Leslie J Crofford; Beverly Welch; Ashley Pinckney; Maureen D Mayes; Keith M Sullivan
Journal:  Ann Rheum Dis       Date:  2019-08-07       Impact factor: 19.103

4.  Generation of a novel CD30+ B cell subset producing GM-CSF and its possible link to the pathogenesis of systemic sclerosis.

Authors:  K Higashioka; Y Kikushige; M Ayano; Y Kimoto; H Mitoma; M Kikukawa; M Akahoshi; Y Arinobu; T Horiuchi; K Akashi; H Niiro
Journal:  Clin Exp Immunol       Date:  2020-07-14       Impact factor: 4.330

Review 5.  Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis.

Authors:  Gabriela Kania; Michal Rudnik; Oliver Distler
Journal:  Nat Rev Rheumatol       Date:  2019-05       Impact factor: 20.543

6.  Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients.

Authors:  Dominique Farge; Lucas C M Arruda; Fanny Brigant; Emmanuel Clave; Corinne Douay; Zora Marjanovic; Christophe Deligny; Guitta Maki; Eliane Gluckman; Antoine Toubert; Helene Moins-Teisserenc
Journal:  J Hematol Oncol       Date:  2017-01-19       Impact factor: 17.388

Review 7.  The role of innate immune cells in systemic sclerosis in the context of autologous hematopoietic stem cell transplantation.

Authors:  N H Servaas; J Spierings; A Pandit; J M van Laar
Journal:  Clin Exp Immunol       Date:  2020-02-17       Impact factor: 4.330

Review 8.  Management of Endothelial Dysfunction in Systemic Sclerosis: Current and Developing Strategies.

Authors:  Djúlio César Zanin-Silva; Maynara Santana-Gonçalves; Marianna Yumi Kawashima-Vasconcelos; Maria Carolina Oliveira
Journal:  Front Med (Lausanne)       Date:  2021-12-22

9.  Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation.

Authors:  Kevin Hendrawan; Melissa L M Khoo; Malini Visweswaran; Jennifer C Massey; Barbara Withers; Ian Sutton; David D F Ma; John J Moore
Journal:  Front Immunol       Date:  2022-01-19       Impact factor: 7.561

Review 10.  Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis.

Authors:  Nicoletta Del Papa; Francesca Pignataro; Eleonora Zaccara; Wanda Maglione; Antonina Minniti
Journal:  Front Immunol       Date:  2018-10-16       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.